Aeluma Reports Q2 Financials, Secures New Contracts, and Boosts Cash to $38.6M

summarizeSummary

Aeluma, Inc. reported its second-quarter fiscal 2026 financial results, showing increased net losses but significant operational progress with new contract wins and a strengthened cash position of $38.6 million.

check_boxKey Events

• Q2 Fiscal 2026 Financial Results

  Reported revenue of $1.3 million, a GAAP net loss of $1.9 million, and an Adjusted EBITDA loss of $917 thousand for the quarter ended December 31, 2025. Revenue decreased year-over-year, and net loss increased quarter-over-quarter.

• Strong Cash Position

  Cash and cash equivalents increased significantly to $38.6 million as of December 31, 2025, up from $15.7 million at June 30, 2025, primarily due to $23.385 million in proceeds from a public offering.

• New Contract Wins and Operational Progress

  Awarded new R&D contracts from NASA for quantum technology and RFSUNY for silicon photonics lasers. The company also appointed a Senior Vice President of Business Development and Product, expanded manufacturing engagements, and began taking initial sales orders.

• Reaffirmed Fiscal Year 2026 Guidance

  Aeluma reaffirmed its full fiscal year 2026 revenue guidance in the range of $4.0 million to $6.0 million, emphasizing strategic priorities for new contract wins, team expansion, and enhanced manufacturing readiness.

auto_awesomeAnalysis

Aeluma, Inc. reported mixed second-quarter fiscal 2026 results, with revenue declining year-over-year and net losses increasing quarter-over-quarter. However, the company demonstrated significant operational progress by securing new R&D contracts from NASA and RFSUNY, expanding its leadership team, and advancing its commercialization efforts. Crucially, Aeluma's cash and cash equivalents surged to $38.6 million, largely due to a $23.385 million public offering completed prior to December 31, 2025. This substantial capital infusion provides a strong financial runway, especially in light of recent insider selling and a large resale registration, mitigating immediate liquidity concerns and supporting ongoing R&D and commercialization initiatives.